Treatment of pain symptoms in irritable bowel syndrome patients

Vishal Gupta, Baharak Moshiree, G. Nicholas Verne

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.

Original languageEnglish
Pages (from-to)829-836
Number of pages8
JournalDrugs of Today
Volume40
Issue number10
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Irritable Bowel Syndrome
Pain
Antidiarrheals
Serotonin Agents
Parasympatholytics
Laxatives
Tricyclic Antidepressive Agents
Abdominal Pain
Habits
Hypersensitivity
Therapeutics
Biomarkers

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Treatment of pain symptoms in irritable bowel syndrome patients. / Gupta, Vishal; Moshiree, Baharak; Verne, G. Nicholas.

In: Drugs of Today, Vol. 40, No. 10, 01.10.2004, p. 829-836.

Research output: Contribution to journalArticle

Gupta, Vishal ; Moshiree, Baharak ; Verne, G. Nicholas. / Treatment of pain symptoms in irritable bowel syndrome patients. In: Drugs of Today. 2004 ; Vol. 40, No. 10. pp. 829-836.
@article{6a7ca7aae7dd4e958799f48ab5917477,
title = "Treatment of pain symptoms in irritable bowel syndrome patients",
abstract = "Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.",
author = "Vishal Gupta and Baharak Moshiree and Verne, {G. Nicholas}",
year = "2004",
month = "10",
day = "1",
doi = "10.1358/dot.2004.40.10.863743",
language = "English",
volume = "40",
pages = "829--836",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "10",

}

TY - JOUR

T1 - Treatment of pain symptoms in irritable bowel syndrome patients

AU - Gupta, Vishal

AU - Moshiree, Baharak

AU - Verne, G. Nicholas

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.

AB - Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.

UR - http://www.scopus.com/inward/record.url?scp=8744289770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8744289770&partnerID=8YFLogxK

U2 - 10.1358/dot.2004.40.10.863743

DO - 10.1358/dot.2004.40.10.863743

M3 - Article

VL - 40

SP - 829

EP - 836

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 10

ER -